AUG 05, 2021 6:00 AM PDT

Gene Markers in Mothers Point to the Risk of Preterm Birth

WRITTEN BY: Tara Fernandez

Preterm births—when the baby is born fewer than 37 weeks gestational age—are very common. Experts estimate one in ten babies in the United States is born preterm. Suppose there was a way to predict which pregnant mothers are most at risk for giving birth prematurely. In that case, they could receive personalized care and more intensive clinical monitoring to improve outcomes for themselves and their babies.

Thanks to new research, a simple blood test may offer a solution.

study by researchers at Michigan State University screened 157 healthy expectant mothers, all of which had not previously given birth to preterm babies. Fifty-one of these participants ended up having a preterm birth.

Amidst the plethora of genes being expressed before, during, and after birth, there were two that stood out to the researchers: CRY2 and CLOCK. These genes are part of a group known to influence cell circadian rhythms, in-built time-keeping systems within cells. The team found that mothers with lower CRY2 and CLOCK mRNA levels had an elevated risk of preterm birth. This finding implies that these two genes may be key factors that dictate when labor should commence.

In the future, the researchers propose that a blood test to screen for CRY2 and CLOCK mRNA levels at the 20-week prenatal appointment could help physicians identify mothers most at risk of preterm delivery.

“If we could measure women’s mRNA levels and tell them for their second or third pregnancies, that they aren’t at risk for a preterm birth because their levels are higher (in a normal/healthy range), that would be such a comfort to the mothers who previously had a preterm birth,” said study lead Hanne Hoffmann. 

Sources: Biology of ReproductionMSU.

 


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 18, 2021
Clinical & Molecular DX
A Crystal Ball for Predicting Labor Day
MAY 18, 2021
A Crystal Ball for Predicting Labor Day
Expectant mothers may no longer have to be caught off guard—researchers have identified biomarkers in the blood th ...
JUN 01, 2021
Genetics & Genomics
Sequencing and Identifying SARS-CoV-2 Variants Efficiently
JUN 01, 2021
Sequencing and Identifying SARS-CoV-2 Variants Efficiently
  Viral surveillance can give researchers vital information about virus origins, transmission routes, affected popu ...
JUL 15, 2021
Technology
Raman Spectroscopy Helps Track IBD Patient Response to Treatment
JUL 15, 2021
Raman Spectroscopy Helps Track IBD Patient Response to Treatment
While there have been multiple methods of evaluating whether a patient with inflammatory bowel disease (IBD) is respondi ...
JUL 20, 2021
Clinical & Molecular DX
Wearable Health Monitors Powered by Sweaty Fingertips
JUL 20, 2021
Wearable Health Monitors Powered by Sweaty Fingertips
Fingertips have thousands of sweat-producing glands, churning out anywhere from 100 to 1,000 times more sweat than other ...
JUL 27, 2021
Clinical & Molecular DX
Thumb-Sized Device Tells You if Your Breath Stinks
JUL 27, 2021
Thumb-Sized Device Tells You if Your Breath Stinks
People generally can’t smell their own breath. So, for individuals with halitosis—or bad breath—friend ...
SEP 21, 2021
Clinical & Molecular DX
Kidney Failure in COVID Survivors
SEP 21, 2021
Kidney Failure in COVID Survivors
New findings indicate that individuals who survive COVID-19 infections, even mild ones, have a significantly elevated ri ...
Loading Comments...